Evidence map›Paper›PMID 42751256›Full record

ReviewWorld journal of transplantation2026

Alemtuzumab or basiliximab: Rethinking induction choice beyond acute rejection in kidney transplantation.

Pranjal Kashiv, Khushboo Saxena, Manish Ramesh Balwani, Amit Pasari, Vivek B Kute

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in World journal of transplantation, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Pranjal KashivDepartment of Nephrology, All India Institute of Medical Sciences, Nagpur, Nagpur 441108, Mahārāshtra, India.
Khushboo SaxenaDepartment of Nephrology, Institute of Kidney Diseases and Research Center, Ahmedabad 380016, Gujarāt, India.
Manish Ramesh BalwaniDepartment of Nephrology, Saraswati Kidney Care Center, Nagpur 440015, Maharashtra, India.
Amit PasariDepartment of Nephrology, Jawaharlal Nehru Medical College, Datta Meghe Institute of Higher Education and Research, Wardha 442001, Maharashtra, India.
Vivek B KuteDepartment of Nephrology, Institute of Kidney Diseases and Research Center, Dr HL Trivedi Institute of Transplantation Sciences, Ahmedabad 380016, Gujarat, India. drvivekkute@rediffmail.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In this review summarizes studies presenting a propensity-matched comparative analysis evaluating alemtuzumab

Indexed as

AlemtuzumabBasiliximabInduction immunosuppressionKidney transplantationLong-term graft outcomes

Identifiers

PMID42751256
PMCPMC13579399

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.